Objective. The aim of this study was to describe the distribution of nodal
disease in FIGO Stage IIIc endometrial cancer (EC) and to evaluate whether
nodal distribution is related to recurrence and survival.
Methods. Charts from EC patients with FIGO Stage IIIc disease from 1989 to
1998 were abstracted for clinicopathologic data, pelvic (PLN) and para-aort
ic (PALN) nodal involvement, number of positive/removed nodes, and extranod
al disease spread. Patterns of nodal distribution were evaluated for site o
f first recurrence and survival. Associations between variables were tested
by chi (2) and Wilcoxon rank sums. Survival analyses were performed by the
Kaplan-Meier method.
Results. Of 607 EC patients evaluated, 47 were identified with FIGO Stage I
IIc disease. All 47 patients underwent hysterectomy and PLN sampling, and 4
2/47 had PALN sampling. The median number of PLN removed was 16 (range 2-35
), and the median number of PALN was 7 (0-18). Stage IIIc disease was defin
ed by positive PLN alone in 43%, positive PLN and PALN in 40%, and positive
PALN alone in 17%. Positive peritoneal cytology and/or adnexal metastasis
were present in 12 patients. Only 1/12 of these patients had isolated posit
ive PLN whereas 11/12 had positive PALN (P = 0.007). An increasing number o
f positive PLN was associated with PALN metastasis (P = 0.0001), and of the
10 patients with bilateral PLN involvement, 9/10 also had positive PALN (P
= 0.001). Sites of first recurrence were similar regardless of whether PAL
N were positive. At a median follow-up of 37 months, the 3-year survival es
timate was 70% for patients with positive PALN versus 87% for those with is
olated PLN disease (P = 0.22). For all patients neither the total number of
positive PLN nor the total number of PLN or PALN removed was associated wi
th survival.
Conclusions. PALN involvement is common in patients with FIGO Stage IIIc en
dometrial cancer, suggesting that PLN sampling alone may result in underdia
gnosis of disease. Patients with positive PALN had more extensive disease,
but survival and patterns of failure were not significantly different from
those with disease confined to PLN, suggesting that lymph node dissection m
ay have a therapeutic role. (C) 2001 Academic Press.